Guardian Pharmacy Services, Stock Annual Yield
| GRDN Stock | 20.33 0.57 2.73% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Guardian Pharmacy's long-term financial health and intrinsic value.
Guardian | Annual Yield | Build AI portfolio with Guardian Stock |
Guardian Pharmacy Services, Company Annual Yield Analysis
Guardian Pharmacy's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Guardian Annual Yield Driver Correlations
Understanding the fundamental principles of building solid financial models for Guardian Pharmacy is extremely important. It helps to project a fair market value of Guardian Stock properly, considering its historical fundamentals such as Annual Yield. Since Guardian Pharmacy's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Guardian Pharmacy's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Guardian Pharmacy's interrelated accounts and indicators.
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
Guardian Dividend Yield
Dividend Yield |
|
In accordance with the recently published financial statements, Guardian Pharmacy Services, has an Annual Yield of 0.0%. This indicator is about the same for the Consumer Staples Distribution & Retail average (which is currently at 0.0) sector and about the same as Consumer Staples (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Guardian Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardian Pharmacy's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guardian Pharmacy could also be used in its relative valuation, which is a method of valuing Guardian Pharmacy by comparing valuation metrics of similar companies.Guardian Pharmacy is currently under evaluation in annual yield category among its peers.
Guardian Pharmacy ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Guardian Pharmacy's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Guardian Pharmacy's managers, analysts, and investors.Environmental | Governance | Social |
Guardian Fundamentals
| Profit Margin | (0.07) % | ||||
| Operating Margin | (0.33) % | ||||
| Current Valuation | 1.29 B | ||||
| Shares Outstanding | 9.2 M | ||||
| Shares Owned By Insiders | 0.96 % | ||||
| Shares Owned By Institutions | 99.04 % | ||||
| Number Of Shares Shorted | 753.91 K | ||||
| Price To Book | 9.80 X | ||||
| Price To Sales | 1.07 X | ||||
| Revenue | 1.23 B | ||||
| Gross Profit | 231.84 M | ||||
| EBITDA | (43.43 M) | ||||
| Net Income | (71.03 M) | ||||
| Total Debt | 30.13 M | ||||
| Book Value Per Share | 2.02 X | ||||
| Cash Flow From Operations | 57.96 M | ||||
| Short Ratio | 8.66 X | ||||
| Earnings Per Share | (1.38) X | ||||
| Target Price | 24.33 | ||||
| Number Of Employees | 3.4 K | ||||
| Market Capitalization | 1.25 B | ||||
| Total Asset | 320.81 M | ||||
| Retained Earnings | 17.12 M | ||||
| Working Capital | 7.86 M | ||||
| Net Asset | 320.81 M |
About Guardian Pharmacy Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guardian Pharmacy Services,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardian Pharmacy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardian Pharmacy Services, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Guardian Pharmacy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.Moving together with Guardian Stock
Moving against Guardian Stock
| 0.84 | DG | Dollar General | PairCorr |
| 0.72 | DLTR | Dollar Tree | PairCorr |
| 0.68 | SYY | Sysco | PairCorr |
| 0.58 | VERU | Veru Inc Earnings Call This Week | PairCorr |
| 0.5 | PFGC | Performance Food | PairCorr |
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services, to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Guardian Pharmacy Piotroski F Score and Guardian Pharmacy Altman Z Score analysis. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.